Cardinal Health, Inc. (NYSE:CAH) Receives $266.56 Consensus PT from Brokerages

Posted by Brenda Bartman on Sep 21st, 2026

Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nineteen research firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $266.5625.

CAH has been the subject of several research analyst reports. Citigroup increased their target price on Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Evercore reaffirmed an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. Bank of America boosted their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Finally, JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th.

Check Out Our Latest Stock Analysis on Cardinal Health

Cardinal Health Trading Down 0.2%

NYSE CAH opened at $224.95 on Monday. The stock has a market cap of $52.32 billion, a P/E ratio of 31.11, a PEG ratio of 1.35 and a beta of 0.51. The company’s fifty day simple moving average is $233.74 and its 200-day simple moving average is $219.79. Cardinal Health has a 52 week low of $145.87 and a 52 week high of $258.30.

Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s revenue was up 5.8% on a year-over-year basis. During the same period last year, the business earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, research analysts expect that Cardinal Health will post 12.55 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 28.49%.

Insider Activity

In other Cardinal Health news, insider Jessica L. Mayer sold 29,436 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider owned 33,076 shares of the company’s stock, valued at $7,812,220.44. This trade represents a 47.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Deborah Weitzman sold 7,354 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This represents a 8.63% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 210,271 shares of company stock valued at $49,626,657 over the last three months. 0.12% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Altus USA Inc. bought a new position in shares of Cardinal Health during the second quarter worth about $55,000. National Pension Service lifted its position in Cardinal Health by 3.8% in the 2nd quarter. National Pension Service now owns 477,491 shares of the company’s stock valued at $113,433,000 after purchasing an additional 17,492 shares during the last quarter. WINTON GROUP Ltd boosted its stake in Cardinal Health by 394.9% during the 2nd quarter. WINTON GROUP Ltd now owns 44,405 shares of the company’s stock valued at $10,549,000 after purchasing an additional 35,432 shares during the period. Summit Financial Strategies Inc. bought a new position in Cardinal Health in the 2nd quarter worth about $202,000. Finally, Community Bank N.A. grew its position in Cardinal Health by 89.5% in the 2nd quarter. Community Bank N.A. now owns 417 shares of the company’s stock worth $99,000 after purchasing an additional 197 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health, Inc is a healthcare services and products company that supports the pharmaceutical and medical industries. Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, over-the-counter products and consumer health items to pharmacies, hospitals, health systems and other healthcare providers. The segment also provides specialty pharmaceutical services, nuclear and radiopharmaceutical products, and related support for manufacturers and providers.

Through its Global Medical Products and Distribution segment, Cardinal Health manufactures, sources and distributes medical and surgical products, including gloves, gowns, syringes, exam-room supplies and other essential equipment.